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Abstract 29 
The malaria parasite replicates within erythrocytes. The pathogenesis of clinical malaria is in large part 30 
due to the capacity of the parasite to remodel its host cell. To do this, intraerythrocytic stages of 31 
Plasmodium falciparum export more than 300 proteins that dramatically alter the morphology of the 32 
infected erythrocyte as well as its mechanical and adhesive properties. P. falciparum plasmepsin V 33 
(PfPMV) is an aspartic protease that processes proteins for export into the host erythrocyte and is thought 34 
to play a key role in parasite virulence and survival. However, although standard techniques for gene 35 
disruption as well as conditional protein knockdown have been previously attempted with the pfpmv gene, 36 
complete gene removal or knockdown was not achieved so direct genetic proof that PMV is an essential 37 
protein has not yet been established. Here we have used a conditional gene excision approach combining 38 
CRISPR-Cas9 gene editing and DiCre-mediated recombination to functionally inactivate the pfpmv gene. 39 
The resulting mutant parasites displayed a severe growth defect. Detailed phenotypic analysis showed 40 
that  development of the mutant parasites was arrested at the ring-to-trophozoite transition in the 41 
erythrocytic cycle following gene excision, likely due to a defect in protein export. Our findings are the 42 
first to elucidate the effects of PMV gene disruption, showing that it is essential for parasite viability in 43 
asexual blood stages. The mutant parasites can now be used as a platform to further dissect the 44 
Plasmodium protein export pathway. 45 
  46 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/404798doi: bioRxiv preprint first posted online Sep. 6, 2018; 
3 
 
Introduction 47 
 Malaria was responsible for approximately 445,000 deaths and 216 million clinical cases in 2016, 48 
an increase of ~5 million cases over the previous year [1]. Vital to the growth and pathogenicity of the 49 
parasite is host cell remodelling in which the parasite modifies the host erythrocyte by the synthesis and 50 
export of over 300 parasite proteins beyond the bounds of the parasitophorous vacuole (PV) within which 51 
it replicates (for reviews, see [2,3]). The exported proteins are trafficked from the parasite to the host 52 
erythrocyte via a putative parasite-derived protein complex known as the translocon of exported proteins 53 
(PTEX), located within the PV membrane (PVM) [4,5]. The exported proteins extensively alter the 54 
mechanical and adhesive properties of infected erythrocytes, resulting in vascular sequestration of the 55 
infected cells and eventual destruction of the host erythrocyte [6]. Protein export in Plasmodium has been 56 
most intensively studied in P. falciparum (reviewed in [7,8]), where the majority of known exported 57 
proteins contain the pentameric localisation motif RxLxE/Q/D, termed Plasmodium export element 58 
(PEXEL), typically located downstream of the N-terminal secretory signal sequence that regulates entry 59 
into the ER [9,10]. Some proteins lacking a PEXEL motif, referred to as PEXEL-negative exported 60 
proteins (PNEPs), can also be exported [11]. PNEPs do not contain  a typical secretory signal sequence so 61 
are unlikely to be N-terminally processed , but the first 20 amino acid residues of PNEPs are sufficient to 62 
mediate  their export. The unfolding of soluble PNEPs is then required for trafficking  into the host cell 63 
[12].  64 
P. falciparum plasmepsin V (PfPMV) is an ER-located aspartic protease comprising 590 amino acid 65 
residues (~68 kDa) [13]. PfPMV expression levels in the parasite progressively increase throughout 66 
schizogony [13]. Numerous studies have now established that PMV is directly responsible for cleavage of 67 
the PEXEL motif within exported proteins. Cleavage occurs on the C-terminal side of the conserved Leu 68 
residue (RxL↓), revealing a new N-terminus that is rapidly acetylated (Ac-xE/Q/D) [14]. A recent x-ray 69 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/404798doi: bioRxiv preprint first posted online Sep. 6, 2018; 
4 
 
crystal structure of Plasmodium vivax PMV (PvPMV) revealed a canonical aspartyl protease fold with 70 
several important features [15]. These include a nepenthesin (NAP)-like insertion within the N-terminal 71 
part of the enzyme, which may control substrate entry into the active site and influence enzyme 72 
specificity, as well as a helix-turn-helix (HTH) motif near the C-terminus of the enzyme, which is 73 
conserved in PMV from other Plasmodium species but not found in other parasite plasmepsins involved 74 
in haemoglobin digestion. PMV also possesses an unpaired Cys residue (C140 in PvPMV, equivalent to 75 
C178 in the P. falciparum enzyme) which is located in the flap of the structure and is restricted to 76 
Plasmodium species. In attempts to establish the druggability and function of PMV, several 77 
peptidomimetic inhibitors based on the PEXEL motif have been developed [16-18]. A co-crystal structure 78 
of PMV bound to one of these compounds, the PEXEL-mimetic WEHI-842, showed that although the 79 
unpaired Cys points into the active site of the enzyme, it does not appear to make contact with the 80 
inhibitor [15,19]. Another inhibitor, WEHI-916, inhibits the activity of purified PMV isolated from both 81 
P. falciparum and P. vivax, and higher concentrations of WEHI-916 were required to kill parasites 82 
engineered to over-express PfPMV indicating on-target efficacy [16,18]. Compound 1, a hydroxyl-83 
ethylamine PEXEL-mimetic, inhibited PfPMV activity in vitro with picomolar potency but failed to 84 
block parasite growth due to poor stability and membrane permeability [17]. Collectively, these findings 85 
indicate that PMV has a number of distinguishing features that could be exploited in drug design, and can 86 
potentially be targeted with suitable inhibitory compounds. 87 
 An important component in the validation of any enzyme as a drug target is genetic ablation of 88 
enzyme expression. Unfortunately, previous attempts to genetically delete or knock-down PMV 89 
expression have been only partially successful. Work by Boddey et al [20] failed to disrupt the P. berghei 90 
PMV (PbPMV), suggesting (but not proving) that the gene is essential. Russo et al [21] similarly 91 
attempted to disrupt the pfpmv gene using an allelic replacement approach. Single crossover homologous 92 
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recombination into the endogenous PMV locus was possible only when the catalytic dyad aspartate codon 93 
was preserved, whilst four separate transfection experiments with constructs designed for non-94 
synonymous alteration of the active site codon were not successful. Conditional knockdown of PfPMV 95 
expression was also attempted using the RNA-degrading glmS ribozyme system [18]. Although this 96 
resulted in around 75-90% knockdown of PMV expression, the remaining PMV levels were presumably 97 
sufficient to enable export and sustain parasite development. Gambini et al [17] generated an inducible 98 
PMV knock-down by fusing PMV with a destabilising domain (DD), but only a 4 to 10-fold knock-down 99 
of PMV cellular levels was achieved using this approach, which did not affect parasite viability. In 100 
summary, whilst some of these data are consistent with an essential role for PMV, in the absence of any 101 
reports of complete ablation of PfPMV expression, direct genetic proof that PMV is an essential protein is 102 
lacking. 103 
 Here we have used a robust conditional genetic approach to truncate the pfpmv gene. Our findings 104 
are the first to confirm genetically that deletion of PfPMV has a significant effect on ring-to-trophozoite 105 
development and ultimately results in parasite death. 106 
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Results 108 
Generation of modified pfpmv parasites using CRISPR-Cas9 109 
Previous attempts to disrupt the pfpmv gene using conventional genetic techniques were 110 
unsuccessful [20,21], and conditional knockdown approaches did not significantly affect PEXEL 111 
processing or parasite viability [17,18], presumably due to relatively low levels of PfPMV expression 112 
being sufficient to sustain parasite viability. To explore the consequences of complete functional 113 
inactivation of PMV, we therefore took advantage of the  DiCre conditional recombinase system, recently 114 
adapted to P. falciparum [22]. Using Cas9-mediated genome editing [23] we first introduced synthetic 115 
introns containing loxP sites [24] into the endogenous pfpmv locus such that they flanked (floxed) an 116 
internal segment of the gene encoding Asp133 to Thr590. At the same time, the modified gene was fused 117 
to a C-terminal HA3 epitope tag, as well as a 2A sequence followed by the aminoglycoside 3'-118 
phosphotransferase (neo-R) gene sequence conferring neomycin resistance activity to enable selection for 119 
integration events (Fig 1A). Importantly, one of the PfPMV catalytic dyad residues (Asp365) is included 120 
within the floxed region. The repair plasmid pT2A-5´UTR-3´-PMV- ΔDHFR was based on pT2A-DDI-121 
1cKO, which contains a modified selection-linked integration (SLI) region [25]. The genomic 122 
modification was made in the DiCre-expressing P. falciparum B11 parasite clone [26] such that excision 123 
of the floxed sequence could be induced by treatment of the transgenic parasites with rapamycin (RAP). 124 
DiCre-mediated excision was predicted to generate an internally-truncated mutant form of PMV lacking 125 
one of the catalytic dyad residues. Excision would also remove the neo-R gene and induce expression of 126 
GFP as a fluorescence reporter indicative of parasites expressing the truncated pfpmv gene (Fig 2A).  127 
 128 
 129 
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Fig 1. Generation of P. falciparum parasite lines expressing PfPMV-HA. (A) Using Cas9-mediated 131 
recombination, the region of the pfpmv gene encoding Asp133 to Thr590 was replaced with two loxP 132 
(black arrowhead)-containing P. falciparum SERA2 introns (yellow box) flanking a recondonised pfpmv 133 
(blue box) fused to a 3xHA epitope tag (purple box), a 2A sequence (pink box), and a neo-R gene (white 134 
box) and stop codon (red hexagon). The second loxPint was also fused with 2A and gfp gene sequences. 135 
The gfp gene is translated only following site-specific recombination of the loxP sites by DiCre 136 
recombinase. Positions of hybridisation of primers used for confirmation of the integration event by 137 
diagnostic PCR are shown as coloured arrows. (B) Diagnostic PCR analysis of genomic DNA of the 138 
control parental B11 and integrant P. falciparum clones, confirming the predicted homologous 139 
recombination event.  140 
 141 
Fig 2. DiCre-mediated conditional disruption of P. falciparum PMV expression. (A) Strategy for 142 
conditional truncation of the pfpmv gene. Positions of hybridisation of primers used for diagnostic PCR 143 
analysis of the integration and excision events are shown as coloured arrows. (B) Diagnostic PCR 144 
analysis of genomic DNA from transgenic P. falciparum PMV-C5 line at 24 h in cycle 0 (~20 h post 145 
RAP- or DMSO-treatment), confirming the predicted DiCre-mediated excision events. Expected sizes of 146 
the PCR amplicons specific for the intact or excised locus are indicated. (C) Live GFP fluorescence assay 147 
of cycle 0 PMV-C5 parasites ∼42 h following treatment at ring stage with DMSO or RAP. Parasite nuclei 148 
were stained with Hoechst 33342. (D) Giemsa-stained blood smears, showing the morphology of treated 149 
PMV-C5 parasites. The time-course of treatment and subsequent monitoring of the cultures is indicated 150 
(top). 151 
 152 
 153 
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 154 
 Successful modification of the pfpmv gene in the transfected parasite population following the 155 
introduction of the targeting vector was confirmed by diagnostic PCR (data not shown). Limiting dilution 156 
cloning of the modified parasites resulted in the isolation of parasite clones PMV-C5 and PMV-F9, which 157 
were derived from independent transfections using different guide RNAs. Modification of the native 158 
pfpmv locus was confirmed in both transgenic parasite lines by diagnostic PCR (Fig 1B). Both clones 159 
replicated at a rate indistinguishable from that of the parental B11 parasites, suggesting that the 160 
modifications did not affect  parasite viability. Transgenic parasite clone PMV-C5 was used for all 161 
subsequent experiments.  162 
 163 
Conditional truncation of the pfpmv gene leads to a developmental arrest 164 
 Expression of the recodonised pfpmv gene in transgenic parasite clone PMV-C5 was expected to 165 
produce an epitope-tagged PMV product (called PMV-HA), as well as expression of the neo-R gene 166 
product. Note that in this event GFP is not produced because of the presence of a translational stop codon 167 
directly downstream of the neo-R gene. Upon RAP-treatment, site-specific recombination between the 168 
introduced loxP sites in the modified pfpmv locus of the PMV-C5 parasites was anticipated to reconstitute 169 
a functional, albeit chimeric, intron. Splicing of this chimeric intron results in a truncated form of PMV 170 
lacking the HA epitope tag, as well as allowing expression of free GFP. DNA extracts of RAP-treated and 171 
mock-treated (DMSO-treated control) PMV-C5 parasites were analysed by diagnostic PCR (Fig 2A). To 172 
confirm whether RAP-induced DiCre-mediated excision took place as expected, we monitored the 173 
appearance of GFP-positive parasites following treatment of synchronous ring-stage parasites with 174 
DMSO or RAP. As expected, GFP fluorescence was only detected in the RAP-treated parasites (Fig 2C). 175 
Indeed, no parasites lacking GFP fluorescence could be detected upon microscopic examination of the 176 
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RAP-treated cultures, indicating highly efficient excision of the floxed pfpmv sequence. This was 177 
confirmed by FACS analysis (Fig 3B), showing that 98.86 % of the RAP-treated parasites displayed GFP 178 
fluorescence. These results confirmed the PCR-derived excision data and demonstrated essentially 179 
complete conditional truncation of PMV within a single erythrocytic cycle in the PMV-C5 parasite clone. 180 
 181 
Fig 3. Functional disruption of PfPMV results in developmental arrest at the ring-to-trophozoite 182 
transition. (A) Growth assay showing relative replication rates over the two erythrocytic cycles 183 
following treatment of PMV-C5 ring stages with DMSO or RAP. Parasite number values were 184 
determined by FACS as described in Materials and Methods. (B) GFP fluorescence at ∼42 h (schizonts) 185 
of the PMV-C5 line treated at ring stage with DMSO (black) or RAP (green) as determined by flow 186 
cytometry of fixed cultures. The percentage of GFP-positive RAP-treated parasites (i.e. the excision rate) 187 
was 98.86%. (C) Western blot analysis of clone PMV-C5 following mock-treatment (-RAP) or RAP-188 
treatment (+RAP). Schizont extracts (∼42 h post-treatment) were probed with antibodies to detect HA-189 
tagged PfPMV (anti-HA), or antibodies to GFP, MSP1, KAHRP, or HRP2. 190 
 191 
 To initially explore the effects of PMV truncation on parasite viability, we examined growth and 192 
development of the ΔPMV mutant by microscopic examination of Giemsa-stained cultures. This revealed 193 
that although RAP-treated PMV-C5 parasites appeared morphologically normal throughout the 194 
erythrocytic growth cycle in which the parasites were treated (henceforward referred to as cycle 0), 195 
development of the mutant parasites stalled at ring stage in the following cycle (cycle 1; Fig 2D). By the 196 
end of cycle 1, only arrested pycnotic forms were observed. Collectively, these results suggested that 197 
ablation of PMV expression causes a severe growth defect and developmental arrest between ring and 198 
trophozoite stage. 199 
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 200 
Egress, Invasion and Protein export are not affected by disruption of the 201 
pfpmv gene in cycle 0 202 
 Whilst the above results showed that truncation of PfPMV affected parasite development in cycle 203 
1, it did not rule out the possibility of defects in egress and invasion of fresh erythrocytes at the end of 204 
cycle 0 (the cycle of RAP-treatment). To evaluate and quantify this, we used flow cytometry to monitor 205 
increases in parasitaemia at the transition between cycle 0 schizonts and cycle 1 rings. As shown in Fig 206 
3A, the parasitaemia of PMV-C5 cultures at the end of cycle 0 as well as at the early ring stage of cycle 1 207 
was unaffected by RAP-treatment, indicating no effects of PMV ablation on schizont development in 208 
cycle 0, or the egress and invasion capacity of the released merozoites. However, upon further 209 
development of the new parasite generation in cycle 1, the parasitaemia in the RAP-treated culture 210 
reached plateau after the ring-trophozoite transition. This confirmed that the truncation of PfPMV did not 211 
cause any effects on egress and invasion and that the enzyme is essential for the ring to trophozoite 212 
developmental transition of the intracellular parasite. Confirmation of the high excision rate of the PMV-213 
C5 clone following RAP-treatment was also confirmed by FACS analysis (Fig 3B).  214 
 To further explore the PMV-null phenotype, we examined the expression of PMV-HA as well as 215 
other non-exported and exported parasite proteins. Extracts of DMSO and RAP-treated PMV-C5 216 
parasites were analysed by immunoblot ∼42 h following treatment, using antibodies specific for the HA 217 
epitope tag as well as GFP, the merozoite plasma membrane surface protein MSP1, and the exported 218 
proteins KAHRP and HRP2. As shown in Fig 3C, only a faint HA signal was detected in the RAP-treated 219 
sample, whilst a corrrespondingly strong GFP signal was observed only in this sample. These data were 220 
in good agreement with the diagnostic PCR results, indicating high efficiency of conditional excision of 221 
the floxed sequence in the PMV-C5 clone. In contrast, no differences between DMSO- and RAP-treated 222 
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parasites were detectable in expression levels of MSP1 (thought to play an important role in egress and 223 
invasion [27]) Similarly, there were no significant differences in expression of KAHRP and HRP2, both 224 
of which are examples of PEXEL-containing proteins that are cleaved by PMV [20,21,28]. This is 225 
consistent with the notion that protein export remains unaffected in cycle 0 in the RAP-treated parasites. 226 
 We next determined the effects of PfPMV truncation on its subcellular localisation within the 227 
parasite, as well as on the trafficking of other exported proteins in cycle 0. Immunofluorescence analysis 228 
(IFA) showed that, as expected, PMV-HA showed a perinuclear localisation in schizonts of control PMV-229 
C5 parasites but the signal was lost in RAP-treated parasites (Fig 4). To determine the effects of PMV 230 
ablation on protein export, mock- and RAP-treated PMV-C5 parasites were probed with anti-KAHRP2 231 
and anti-HRP2 antibodies. The localisation and intensity of the MSP1 signal and the KHARP signal did 232 
not alter upon RAP-treatment, correlating well with the western blot analysis. The HRP2 signal remained 233 
detectable in both control and the RAP-treated parasites, but in contrast to the situation with the other 234 
proteins examined, the fluorescence intensity of the HRP2 signal was substantially decreased in RAP-235 
treated parasites, suggesting a partial effect of PMV depletion on HRP2 trafficking. Together, these data 236 
confirmed the loss of PMV-HA in RAP-treated parasites whilst indicating that both exported proteins 237 
(KAHRP and HRP2) and merozoite surface proteins still localise correctly in cycle 0. However, the 238 
decreased HRP2 signal intensity was consistent with a partial impact on protein export in cycle 0.  239 
 240 
Fig 4. IFA of schizonts of control (DMSO-treated) and RAP-treated integrant clone PMV-C5 ∼42 h 241 
following treatment (cycle 0). The PMV-HA signal was lost following RAP treatment. Localization of 242 
MSP1, KAHRP and HRP2 was unaffected; however, the HRP2 signal was significantly decreased in 243 
intensity. Parasite nuclei were visualised by staining with DAPI. 244 
  245 
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Discussion 246 
Malarial proteolytic enzymes play regulatory and effector roles in multiple key biological 247 
processes in this important pathogen and have long been of interest as potential drug targets. In this study, 248 
we have shown for the first time that functional ablation of the pfpmv gene leads to a block at the ring-to-249 
trophozoite transition and death of the parasite. To achieve this, we employed the robust conditional 250 
DiCre approach in combination with Cas9-induced gene modification. This system provides a rapid and 251 
efficient means of generating transgenic parasites as well as enabling complete disruption of the gene of 252 
interest [29,30]. Our study demonstrates that DiCre-mediated conditional knockout is a powerful tool to 253 
study essential genes in the human malaria parasite. Our genetic strategy also incorporated a method to 254 
permit the selection of parasites in which genomic integration of the input constructs had taken place, 255 
termed selection-linked integration (SLI), previously developed by Birnbaum et al [25]. For this, our 256 
rescue plasmid contained an SLI-resistance marker (neomycin phosphotransferase), which was linked to 257 
the modified pfpmv gene separated by a 2A ‘skip’ peptide [31,32]. This approach allows selection for 258 
correct integration by one to two weeks of neomycin selection. In our case, with the assistance of Cas9-259 
mediated integration we in fact did not need to use neomycin selection in our experiments to select for 260 
correct integration. However, our plasmids could be useful for future genetic complementation studies.  261 
When the PMV-modified parasite clone PMV-C5 was RAP-treated at early ring stage for just 3 262 
h, followed by removal of RAP, parasite development proceeded normally in the first erythrocytic cycle 263 
(cycle 0). Whilst expression of most of the parasite proteins examined appeared unaffected, we did 264 
observe some impact on expression of the exported parasite protein HRP2. This is reminiscent of the 265 
observation by Russo et al [21] that the levels of HRP2 and RESA (ring-infected erythrocyte surface 266 
antigen) were reduced by 30-50% in PMV mutants. We suspect that this may be due to low levels of 267 
PMV expression early in cycle 0, perhaps due to transcription early in the erythrocytic cycle prior to gene 268 
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excision. That low levels of PMV are sufficient to sustain development has also been indicated by 269 
previous conditional protein knockdown experiments [18]. Egress and invasion at the end of cycle 0 was 270 
not affected in the RAP-treated PMV-C5 parasites; however, parasite development in the next cycle 271 
stalled at the ring-to-trophozoite transition. This phenotype is very similar to that observed upon 272 
treatment with the PMV inhibitor WEHI-916 [18], where the drug-treated parasites showed a growth 273 
defect at the ring-to-trophozoite transition from approximately 20 h post-invasion. A similar parasite 274 
developmental arrest at ring stage was also observed following conditional ablation of the PTEX 275 
component HSP101 [33,34]. This implies that PMV function may be associated with PTEX, and may be 276 
essential for ring-to-trophozoite development.  277 
 In summary, using a DiCre-mediated conditional gene editing approach to selectively disrupt the 278 
pfpmv gene, we have shown that the gene is essential for the ring-to-trophozoite transition of intracellular 279 
growth. This engineered platform will be useful for further study of PEXEL-protein export as well as for 280 
dissection of PMV domain interactions, providing further impetus for focusing on PMV as a new 281 
potential antimalarial drug target. 282 
 283 
  284 
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Materials and Methods 285 
 286 
P. falciparum culture, transfection and limiting dilution cloning 287 
Parasites (wild type clone 3D7 and the DiCre-expressing clone B11 [26]) were routinely cultured 288 
at 37ºC in human erythrocytes at 1-4% haematocrit in RPMI 1640 (Life Technologies) supplemented 289 
with 2.3 gL-1 sodium bicarbonate, 4 gL-1 dextrose, 5.957 gL-1 HEPES, 0.05 gL-1 hypoxanthine, 0.5% 290 
(w/v) Albumax II, 0.025 gL-1 gentamycin sulphate, and 0.292 gL-1 L-glutamine (complete medium) in an 291 
atmosphere of 90% nitrogen, 5% carbon dioxide and 5% oxygen [35,36]. Routine microscopic 292 
examination of parasite growth was performed by fixing air-dried thin blood films with 100% methanol 293 
before staining with 10% Giemsa stain (VWR international) in 6.7 mM phosphate buffer, pH 7.1. For 294 
synchronization, mature schizont stage parasites were isolated on cushions of 70% (v/v) isotonic Percoll 295 
(GE Healthcare) as previously described [37,38]. Enrichment for ring stages following invasion was 296 
performed using 5% (w/v) D-sorbitol [38,39]. 297 
 298 
Cloning of repair plasmid pT2A-5´UTR-3´-PMV- ΔDHFR 299 
pT2A-5´UTR-3´-PMV- ΔDHFR plasmid is based on vector pT2A-DDI-1cKO (a kind gift of Dr. 300 
Edgar Deu, the Francis Crick Institute). The plasmid comprised 5´UTR of pfpmv and nucleotides 1-397 of 301 
pfpmv (Met1 to Lys132), followed by synthetic heterologous loxP-containing sera2 and sub2 introns 302 
(loxPint) [24] flanking recodonised pfpmv sequence encoding residues Asp133 to Thr590 (GeneArt) 303 
fused to a 3xHA epitope tag sequence, a 2A ‘skip’ peptide (2A) [40], and the neomycin resistance gene 304 
(neo). The second loxPint site was immediately followed by another 2A sequence, a gfp gene and 305 
nucleotides 1333 to 1773 of pfpmv which encode Lys445 to Thr590, as a 3´- targeting sequence. 306 
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Overlapping PCR was used to generate the loxPint-2A-gfp fragment from the template pT2A-DDI-1-307 
cKO-complement (obtained from Dr. Edgar Deu, the Francis Crick Institute). The resulting PCR product 308 
was digested with XhoI and ligated into pT2A-DDI-1cKO pre-digested with the same restriction 309 
enzymes, yielding plasmid pT2A-DDI-1-cKO-modified GFP (S1 Fig). The 5´-targeting sequence (903 310 
bp) was PCR amplified from 3D7 genomic DNA using Phusion HF DNA polymerase (NEB) with 311 
forward primer P3.1-BglII_5´UTR_F-mod and reverse primer P2-Int_PMV_R. The recodonised fragment 312 
(1,602 bp) containing loxPint, recondonised pfpmv, 3xHA, and 2A was amplified from the plasmid 313 
17ACRILIP_2177297_endoPMV (GeneArt) with primers P4-PMV_int_F and P5-T2A_HA_R. PCR 314 
products of 5´-target region and the recodonised fragment were ligated with pT2A-DDI-1-cKO-modified 315 
GFP pre-digested with BglII and SalI using In-fusion® HD cloning kit (Clontech, Mountain View, CA), 316 
producing the plasmid pT2A-5´UTR-PMV-cKO. The 3´-target region (441 bp) was amplified from 3D7 317 
genomic DNA using Phusion HF DNA polymerase (NEB) with forward primer P16-EcoRV-PMV-F and 318 
reverse primer P17-EcoRV-PMV-R. This fragment was then ligated into pT2A-5´UTR-PMV-cKO pre-319 
digested with EcoRV, yielding the plasmid pT2A-5´UTR-3´PMV-cKO. The hdhfr gene was removed 320 
from pT2A-5´UTR-3´PMV-cKO by digesting the plasmid with BamHI and EcoRI. The plasmid 321 
backbone was blunt-end using T4 DNA polymerase (NEB) then religated using T4 DNA ligase (NEB), 322 
giving rise to the repair plasmid pT2A-5´UTR-3´-PMV- ΔDHFR. 323 
 324 
Insertion of guide RNA sequences into CRISPR/Cas9 plasmids 325 
Potential guide RNA sequences specifically targeting pfpmv were identified using Benchling 326 
(https://benchling.com/crispr). Two sets of guide RNA sequences were selected. Two pairs of 327 
complementary oligonucleotides (P18-sgPMV-1F and P19-sgPMV-1R; P20-sgPMV-2F, and P21-328 
sgPMV-2R) corresponding to the 19 nucleotides adjacent to the identified PAM sequences were 329 
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phosphorylated using T4 polynucleotide kinase, annealed and ligated into pL-AJP_004 [41] predigested 330 
with BbsI, resulting in the two guide vectors pSgRNA1 and pSgRNA2.  331 
 332 
Generation of pmv-loxPint parasites and conditional PMV truncation 333 
The repair plasmid pT2A-5´UTR-3´-PMV- ΔDHFR was linearized with ScaI prior to 334 
electroporation. Percoll-enriched mature schizonts of P. falciparum clone B11 were electroporated with 335 
20 µg of pSgRNA1 or pSgRNA2 and 60 µg of linearized pT2A-5´UTR-3´-PMV- ΔDHFR using an 336 
Amaxa P3 primary cell 4D Nucleofector X Kit L (Lonza) as described [22]. Twenty-four hours post-337 
transfection, the electroporated parasites were treated with 2.5 nM WR99210 for 96 h to select for 338 
transfectants harbouring pSgRNA plasmids before returning the cultures to medium without drug. 339 
Integrant parasites generally reached parasitaemia levels suitable for cryopreservation within 2-5 weeks. 340 
Detection of the pfpmv-loxPint modified locus was carried out by diagnostic PCR using primer pairs P6-341 
5´UTR_Screen_F and P23-rcPMV-5´integr-R, P6-5´UTR_Screen_F and 198_GFP_start_seq_R, and P24-342 
GFP-3´integr-F and P25-3´UTR-PMV-R. The wild-type pfpmv locus was detected by diagnostic PCR 343 
using primers P6-5´UTR_Screen_F and P22-PMV-endo-R. Transgenic parasite clones were obtained by 344 
limiting dilution cloning by plating a calculated 0.3 parasite per well in flat-bottomed 96-well microplate 345 
wells as described [42]. Wells containing single plaques were subsequently expanded into round-346 
bottomed wells. Transgenic parasite clones (PMV-C5 and PMV-F9) were finally checked by diagnostic 347 
PCR for integration and modification of the endogenous pfpmv gene. Once established, all transgenic 348 
clones were maintained in medium without any drug. 349 
 Recombination between the loxPint sites was induced in tightly synchronised ring-stages of 350 
parasite clone PMV-C5 by incubation for 3 h in the presence of 100 nM RAP in 1% (v/v) DMSO; mock 351 
treatment was with 1% (v/v) DMSO only. DiCre-mediated excision of the floxed pfpmv was detected by 352 
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PCR analysis of parasite genomic DNA using primers P6-5´UTR_Screen_F and P23-rcPMV-5´integr-R, 353 
and P6-5´UTR_Screen_F and Deu198_GFP_start_seq_R. Truncation of PfPMV was evaluated by 354 
immunoblot analysis of SDS extracts of mature Percoll-enriched schizonts, probing with the anti-HA 355 
antibody 3F10 (Roche), followed by horseradish peroxidase-conjugated secondary antibodies. 356 
 357 
Nucleic acid extraction and polymerase chain reaction 358 
 For DNA extraction, total cell pellets were first treated with 0.15% saponin in PBS for 10 min, 359 
then washed with PBS before DNA was extracted using a DNeasy® Blood & Tissue Kit (QIAGEN). For 360 
diagnostic PCR amplification, GoTaq® (Promega) DNA master mix was used. Amplification of 361 
fragments used in construct design was carried out using Phusion® high fidelity DNA polymerase (NEB). 362 
 363 
Indirect immunofluorescence Analysis (IFA) and Western blots 364 
For IFA, thin blood films were prepared from synchronous P. falciparum cultures enriched in 365 
mature schizonts. The air-dried thin films were fixed in 4% (w/v) paraformaldehyde for 30 min, 366 
permeabilised with 0.1% (v/v) Triton X-100 for 10 min, and blocked overnight in 3% (w/v) bovine serum 367 
albumin (BSA) in PBS. Slides were probed with rat anti-HA 3F10 (1:100) to detect HA-tagged proteins, 368 
human anti-MSP1 monoclonal antibody (mAb) X509 (1:500) to detect MSP1, mAb 89 (1:100) to detect 369 
KAHRP, and mAb 2G12 (1:100) to detect HRP2.  Primary antibodies were detected using Alexa Fluor 370 
594-conjugated anti-human or anti-mouse secondary antibodies (Life Technologies), and Alexa Fluor 371 
488-conjugated streptavidin (Life Technologies), diluted 1:2000. Slides were stained with 4,6-diamidino-372 
2-phenylindole (DAPI), mounted in Citifluor (Citifluor Ltd., UK). Images were visualised using a Nikon 373 
Eclipse Ni microscope with LED-illumination with a 63x Plan Apo λ NA 1.4 objective. Images were 374 
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taken using an Orca Flash 4 digital camera controlled by Nikon NIS Element AR 4.30.02 software. All 375 
images were subsequently analysed using FIJI software.  376 
For Western blots, Percoll-enriched schizonts were pelleted, then resuspended into 10 volumes of 377 
PBS. Samples were solubilised into SDS sample buffer, boiled, sonicated and centrifuged. The extracts 378 
were subjected to SDS-PAGE under reducing conditions followed by transfer to nitrocellulose 379 
membrane. Membranes were probed with rat anti-HA 3F10 (1:1000), human anti-MSP1 mAb X509 380 
(1:1000), anti-GFP (1:1000), mAb 89 (1:1000) or mAb 2G12 (1:1000), followed by horseradish 381 
peroxidase-conjugated secondary antibodies. Antigen-antibody interactions were visualised by enhanced 382 
chemiluminescence (SuperSignal West Pico chemiluminescent substrate, Pierce). 383 
 384 
Parasite growth assay 385 
Parasitaemia measurement by FACS was as described previously [43]. Briefly, parasites 386 
recovered at various time-points were fixed in 8% paraformaldehyde 0.04% glutaraldehyde, pH 7.4 and 387 
stained with 2 µM Hoechst 33342 (Invitrogen, Waltham, MA). Parasitaemia was calculated using the 388 
FACS BD Fortessa flow cytometer (BD Biosciences). Briefly, cultures to be analysed were initially 389 
screened using forward and side scatter parameters and gated for erythrocytes. From this gated 390 
population, the proportion of Hoechst-stained cells in 100,000 cells was determined using ultraviolet light 391 
with a violet filter (450/50 nm). Samples were analysed using FlowJo software. 392 
  393 
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